Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 26,100
-500 (-1.88%)
Aug 21, 2026, 3:30 PM KST
Daihan Pharmaceutical Market Cap
Daihan Pharmaceutical has a market cap or net worth of 153.47 billion as of August 21, 2026. Its market cap has decreased by -11.82% in one year.
Market Cap
153.47B
Enterprise Value
54.86B
Revenue
211.44B
Ranking
n/a
PE Ratio
5.69
Stock Price
26,100.00
ChartMarket Cap Chart
Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 153.47B, an increase of 589.43%. That is a compound annual growth rate of 7.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 153.47B | -10.77% |
| Dec 30, 2025 | 171.99B | 11.64% |
| Dec 30, 2024 | 154.06B | -5.59% |
| Dec 28, 2023 | 163.17B | -11.13% |
| Dec 29, 2022 | 183.60B | 6.62% |
| Dec 30, 2021 | 172.20B | -12.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JW Lifescience | 174.98B |
| AptaBio Therapeutics | 174.46B |
| BNC KOREA | 169.62B |
| Hyundai Pharmaceutical | 169.11B |
| Daewon Pharmaceutical | 167.40B |
| Hana Pharm | 150.18B |
| Ilyang Pharmaceutical Co.,Ltd | 149.67B |
| Jeil Pharmaceutical Co.,Ltd | 147.46B |